Free Trial
→ DeFi Coin on Verge of Breakout! (From Crypto 101 Media) (Ad) Free ELVN Stock Alerts

Enliven Therapeutics (ELVN) Institutional Ownership

Enliven Therapeutics logo
$21.47 -0.52 (-2.36%)
As of 01/17/2025 04:00 PM Eastern
Compare

Institutional Ownership Changes (13F Filings) for Enliven Therapeutics (NASDAQ:ELVN)

Current
Institutional Ownership
Percentage
95.08%
Number of
Institutional Buyers
(last 12 months)
29
Total
Institutional Inflows
(last 12 months)
$78.73M
Number of
Institutional Sellers
(last 12 months)
12
Total
Institutional Outflows
(last 12 months)
$57.01M
Get ELVN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Enliven Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ELVN Institutional Buying and Selling by Quarter

Enliven Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
1/17/2025 SG Americas Securities LLC16,629$374K0.0%+66.1%0.034%
12/13/2024Lord Abbett & CO. LLC321,055$8.20M0.0%N/A0.657%
11/27/2024Franklin Resources Inc.20,151$559K0.0%N/A0.041%
11/19/2024Barclays PLC56,217$1.44M0.0%+295.8%0.115%
11/16/2024Geode Capital Management LLC750,208$19.16M0.0%+9.9%1.588%
11/15/2024Barclays PLC56,217$1.44M0.0%+295.8%0.119%
11/15/2024Jane Street Group LLC30,793$786K0.0%-41.9%0.065%
11/15/2024Wellington Management Group LLP70,170$1.79M0.0%+107.0%0.149%
11/15/2024State Street Corp745,944$19.05M0.0%+2.9%1.579%
11/15/2024RA Capital Management L.P.1,061,233$27.10M0.3%-50.0%2.246%
11/15/2024Patient Square Capital LP90,572$2.31M0.9%N/A0.192%
11/15/2024Ikarian Capital LLC499,566$12.76M1.7%-14.8%1.058%
11/15/2024Janus Henderson Group PLC1,041,724$26.61M0.0%+43.0%2.205%
11/15/2024HighVista Strategies LLC112,459$2.87M1.0%-6.1%0.238%
11/14/2024Verition Fund Management LLC10,610$271K0.0%N/A0.022%
11/14/2024Walleye Capital LLC99,416$2.54M0.0%N/A0.210%
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC26,168$668K0.0%+12.7%0.055%
11/14/2024Ally Bridge Group NY LLC234,856$6.00M3.2%N/A0.497%
11/14/2024Acuta Capital Partners LLC296,368$7.57M6.1%-25.5%0.627%
11/13/2024FMR LLC6,296,179$160.80M0.0%+10.6%13.328%
11/13/2024The Manufacturers Life Insurance Company17,282$441K0.0%+25.6%0.037%
11/12/2024Charles Schwab Investment Management Inc.255,277$6.52M0.0%+10.4%0.540%
11/7/2024First Turn Management LLC535,092$13.67M2.2%+29.5%1.133%
11/7/2024Quest Partners LLC21,117$539K0.0%+1,226.4%0.045%
10/25/2024China Universal Asset Management Co. Ltd.9,085$232K0.0%+64.4%0.019%
10/10/2024Exchange Traded Concepts LLC7,483$191K0.0%-60.3%0.016%
10/3/2024 SG Americas Securities LLC10,013$256K0.0%N/A0.021%
8/15/2024The Manufacturers Life Insurance Company13,764$322K0.0%N/A0.029%
8/14/2024Marshall Wace LLP192,100$4.49M0.0%N/A0.408%
8/14/2024Logos Global Management LP595,000$13.91M1.1%-62.2%1.265%
8/14/2024HighVista Strategies LLC119,789$2.80M1.0%-5.6%0.255%
8/8/2024First Turn Management LLC413,243$9.66M1.6%N/A0.879%
8/8/2024Nicholas Investment Partners LP56,072$1.31M0.1%N/A0.119%
8/8/2024American Century Companies Inc.27,651$646K0.0%+44.7%0.059%
8/6/2024Quest Partners LLC1,592$37K0.0%+87.3%0.003%
8/1/2024Rhumbline Advisers49,627$1.16M0.0%+29.9%0.105%
7/26/2024Bank of New York Mellon Corp114,109$2.67M0.0%+49.2%0.243%
5/16/2024California State Teachers Retirement System19,141$337K0.0%-5.8%0.041%
5/16/2024Janus Henderson Group PLC713,911$12.60M0.0%+74.8%1.519%
5/16/2024Blackstone Inc.25,191$443K0.0%N/A0.054%
Bill Gates’ is about to mint millionaires (again) with Stargate. (Ad)

This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.
5/15/2024Baker BROS. Advisors LP114,833$2.02M0.0%N/A0.244%
5/14/2024EntryPoint Capital LLC9,510$167K0.1%N/A0.020%
5/10/2024Vanguard Group Inc.1,183,266$20.81M0.0%-3.9%2.517%
5/7/2024 SG Americas Securities LLC9,430$166K0.0%-30.2%0.020%
4/29/2024China Universal Asset Management Co. Ltd.7,952$140K0.0%+67.0%0.017%
2/13/2024Tower Research Capital LLC TRC5,485$76K0.0%-18.8%0.013%
2/6/2024AJOVista LLC2,046$28K0.0%N/A0.005%
2/6/2024Swiss National Bank36,473$505K0.0%-10.3%0.089%
1/24/2024Mirae Asset Global Investments Co. Ltd.12,305$170K0.0%+9.1%0.030%
1/24/2024China Universal Asset Management Co. Ltd.4,763$66K0.0%N/A0.012%
1/12/2024 SG Americas Securities LLC13,501$187K0.0%+17.8%0.033%
1/5/2024Exchange Traded Concepts LLC8,708$121K0.0%+34.0%0.021%
12/6/2023Citigroup Inc.3,347$46K0.0%-69.1%0.008%
11/13/2023FMR LLC3,676,213$50.22M0.0%-8.1%8.923%
11/8/2023Swiss National Bank40,673$556K0.0%-17.3%0.099%
11/7/2023Barclays PLC13,629$186K0.0%-8.1%0.033%
10/23/2023BML Capital Management LLC50,000$683K0.6%-32.6%0.121%
10/13/2023 SG Americas Securities LLC11,460$157K0.0%N/A0.028%
8/15/2023HighVista Strategies LLC121,073$2.47M1.1%N/A0.294%
8/15/2023Commodore Capital LP2,348,272$47.93M5.4%+35.6%5.707%
8/11/2023VR Adviser LLC2,230,127$45.52M7.3%+0.7%5.423%
8/10/2023Metropolitan Life Insurance Co NY1,279$26K0.0%N/A0.003%
8/4/2023American International Group Inc.11,235$229K0.0%N/A0.027%
8/3/2023Bank of New York Mellon Corp80,924$1.65M0.0%+429.1%0.197%
8/2/2023Bank of Montreal Can191,893$3.95M0.0%N/A0.467%
7/24/2023BML Capital Management LLC74,232$1.52M1.4%-65.0%0.181%
7/20/2023Exchange Traded Concepts LLC6,934$142K0.0%N/A0.017%
7/18/2023Denali Advisors LLC9,900$202K0.1%N/A0.024%
6/1/2023Prelude Capital Management LLC34,062$40K0.0%N/A0.519%
5/16/2023Fairmount Funds Management LLC1,924,938$42.16M7.2%N/A29.353%
5/16/2023Boxer Capital LLC710,644$15.56M0.8%N/A10.836%
5/15/2023Commodore Capital LP1,731,365$37.92M5.8%N/A26.401%
5/15/2023Logos Global Management LP401,229$8.79M1.3%N/A6.118%
5/12/2023Mirabella Financial Services LLP11,670$256K0.0%N/A0.178%
5/11/2023FMR LLC3,163,482$69.28M0.0%N/A48.239%
4/20/2023Dorsey Wright & Associates1,237$27K0.0%N/A0.019%
(Data available from 1/1/2016 forward)

ELVN Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ELVN shares?

During the previous two years, 53 institutional investors and hedge funds held shares of Enliven Therapeutics. The most heavily invested institutionals were FMR LLC ($160.80M), Commodore Capital LP ($47.93M), VR Adviser LLC ($45.52M), Fairmount Funds Management LLC ($42.16M), RA Capital Management L.P. ($27.10M), Janus Henderson Group PLC ($26.61M), and Vanguard Group Inc. ($20.81M).Learn more on ELVN's institutional investors.

What percentage of Enliven Therapeutics stock is owned by institutional investors?

95.08% of Enliven Therapeutics stock is owned by institutional investors. Learn more on ELVN's institutional investor holdings.

Which institutional investors have been buying Enliven Therapeutics stock?

Of the 43 institutional investors that purchased Enliven Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($3.77M), Commodore Capital LP ($2.35M), Fairmount Funds Management LLC ($1.92M), Boxer Capital LLC ($710.64K), Janus Henderson Group PLC ($618.42K), First Turn Management LLC ($535.09K), and Logos Global Management LP ($401.23K).

How much institutional buying is happening at Enliven Therapeutics?

Institutional investors have bought a total of 12,327,121 shares in the last 24 months. This purchase volume represents approximately $274.92M in transactions.

Which Enliven Therapeutics major shareholders have been selling company stock?

Of the 16 institutional investors that sold Enliven Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: RA Capital Management L.P. ($1.06M), Logos Global Management LP ($979.22K), FMR LLC ($325.40K), BML Capital Management LLC ($162.18K), Acuta Capital Partners LLC ($101.33K), Ikarian Capital LLC ($86.99K), and Vanguard Group Inc. ($47.62K).

How much institutional selling is happening at Enliven Therapeutics?

Institutional investors have sold a total of 2,839,828 shares in the last 24 months. This volume of shares sold represents approximately $64.84M in transactions.


Related Companies

This page (NASDAQ:ELVN) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Stunning Trump Exec Order Leaked
This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...
Banyan Hill Publishing | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Buy this coin BEFORE Inauguration Day …
Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...
Weiss Ratings | Sponsored
Most People Are Dead Wrong.
Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...
Brownstone Research | Sponsored
Elon’s New AI Firm REVEALED
Nvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...
Paradigm Press | Sponsored
A deadly mistake in my prediction…
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...
Behind the Markets | Sponsored